Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
LVRNA-021 by AIM Vaccine for Coronavirus Disease 2019 (COVID-19): Likelihood of Approval
LVRNA-021 is under clinical development by AIM Vaccine and currently in Phase III for Coronavirus Disease 2019 (COVID-19). According to...